Ach peak flow, PUs |
138 (125, 151) |
138.5 (119.5, 146.5) |
0.72
(n=11) |
Ach RH, % |
154 (147, 207) |
149 (149, 194) |
0.06
(n=11) |
SNP peak flow, PUs |
125 (113, 126) |
136.5 (127, 143) |
0.14
(n=9) |
SNP RH, % |
160 (151, 177) |
144 (136, 228) |
0.86 (n=9) |
Post occlusive peak flow, PUs |
103 (97, 108) |
142 (104, 134) |
0.07
(n=8) |
PORH, % |
119 (109, 132) |
133 (116, 153) |
0.12 (n=8) |
Measurements before treatment
|
AF patients with recurrence
Median (IQR)
|
AF patients with no recurrence
Median (IQR)
|
P value***
|
Ach peak flow, PUs |
121 (118, 121) |
138 (134, 145) |
0.76
(n=12) |
Ach RH, % |
141 (119, 141) |
196 (162, 200) |
0.64
(n=12) |
SNP peak flow, PUs |
122 (115, 124) |
120 (115, 125) |
1.00
(n=10) |
SNP RH, % |
135 (115, 152) |
173 (156, 179) |
0.11
(n=10) |
Post occlusive peak flow, PUs |
101 (98, 103) |
104 (94, 107) |
1.00
(n=9) |
PORH, % |
116 (101, 119) |
129 (127, 142) |
0.11 (n=9) |
(Measurements at time of follow up – before treatment)
|
AF patients with recurrence
Median (IQR)
|
AF patients with no recurrence
Median (IQR)
|
P value***
|
Change in Ach RH, % |
-2 (-23, +17) |
-23 (-33, -16) |
0.42
(n=11) |
Change in SNP RH at time of follow up, % |
-4 (-25, +16) |
-10 (-29,
+23) |
0.90 (n=9) |
Change in PORH at time of follow up, % |
+22 (+18, +24) |
+14 (+11,
+14) |
1.00 (n=8) |
(Measurements at time of follow up – before treatment)
|
AF patients on sotalol
Median (IQR)
|
AF patient not on sotalol
Median (IQR)
|
P value***
|
Change in Ach RH, % |
-31 (-37, -31) |
-16 (-22, +15) |
0.25
(n=11) |
Change in SNP RH at time of follow up, % |
-10 (-23, -4) |
-4 (-33,
+54) |
0.90 (n=9) |
Change in PORH at time of follow up, % |
+22 (-10, +24) |
+14 (+14,
+25) |
0.79 (n=8) |